NCT07388758 2026-02-05Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal CarcinomaSun Yat-sen UniversityPhase 2 Not yet recruiting37 enrolled
NCT07331428 2026-01-09MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPCFujian Cancer HospitalPhase 2 Not yet recruiting25 enrolled